Back

Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Hypertension treatment old and new Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Anca Daniela Farcas

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)

9 More presentations in this session

Presentation thumbnail
Rates of adherence to modern antihypertensive drugs in resistant hypertension
Doctor E. Kocianova (Olomouc, CZ)
Abstract Slides
Presentation thumbnail
Non-steroid anti-inflammatory drug consumption decrease antihypertensive treatment efficacy in postenopausal women
Professor N. Izmozherova (Yekaterinburg, RU)
Abstract
Presentation thumbnail
Long-term treatment with LCZ696 (sacubitril/valsartan) improves cardiac and renal function in stroke-prone spontaneously hypertensive rats
Professor Y. Takeda (Uchinada, JP)
Abstract Slides
Presentation thumbnail
Effect of perindopril/indapamide/amlodipine fixed-dose combination on peripheral and central hemodynamics and vascular wall stiffness parameters in patients with uncontrolled hypertension
Doctor T. Netchessova (Minsk, BY)
Abstract Slides
Presentation thumbnail
CHINA STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive Patients: A one-year registry (CHINA STATUS III)
Mr Z. Du (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Hypertension treatment old and new

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources